100 results
Page 5 of 5
8-K
EX-1.1
at6wj5qa7 xwy52dlu
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
c28lh6o8qi6 d8p
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
v3w1ax
27 Oct 14
Definitive proxy
12:00am
PRER14A
boc5ff65dp8ed8fac9v
23 Oct 14
Preliminary revised proxy
12:00am
10-K
3ng bhc05dn3
29 Sep 14
Annual report
12:00am
8-K
EX-10.1
cwrv1
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
7bk6jo4hpii
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
10-12G/A
EX-99.1
gy5ap46pmc
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
bur80f3w
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.5
78o7oib5awgjxixf
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
csk224z6
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
nh2bsl0prr
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
krhdtydfme2cjvl65j4
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-99.1
fzro0rk
8 Aug 13
Registration of securities
12:00am
10-12G
EX-3.2
jii2ly0dn9 d05
8 Aug 13
Registration of securities
12:00am
10-12G
EX-3.1
38fffulusv73sf bc
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.2
1r8 dw0bw
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.3
5n0vvrncbar jxp0
8 Aug 13
Registration of securities
12:00am